Dean L. Schorno - Feb 2, 2023 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
EVP & Chief Financial Officer
Signature
/s/ Raymond Furey (Attorney-in-Fact)
Stock symbol
RIGL
Transactions as of
Feb 2, 2023
Transactions value $
-$8,946
Form type
4
Date filed
2/6/2023, 04:40 PM
Previous filing
Jan 30, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Sale -$8.95K -5.39K -2.67% $1.66 197K Feb 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.